Journal article
Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression
Olivia M Dean, Alyna Turner, Gin S Malhi, Chee Ng, Sue M Cotton, Seetal Dodd, Jerome Sarris, Yuval Samuni, Michelle Tanious, Nathan Dowling, Astrid Waterdrinker, Deidre Smith, Michael Berk
Revista Brasileira de Psiquiatria | ASSOC BRASILEIRA PSIQUIATRIA | Published : 2015
Grants
Funding Acknowledgements
The authors would like to acknowledge the support of the National Health and Medical Research Council (NHMRC) and The Cooperative Research Centre for Mental Health. We would also like to acknowledge the service support of Barwon Health, Deakin University, The Melbourne Clinic, University of Melbourne, University of Sydney, and the Royal North Shore Hospital. The trial agents were donated by Bioceuticals and supplied by Catalent and Nutrition Care.OMD has received grant support from the Brain and Behavior Foundation, Simons Autism Foundation, Stanley Medical Research Institute, and the National Health and Medical Research Council (NHMRC). SD has received research support from the Stanley Medical Research Institute, NHMRC, Beyond Blue, ARHRF, Simons Foundation, and Geelong Medical Research Foundation. JS is sponsored by a CR Roper Fellowship and has received grant support from NHMRC. MB has received grant support from the National Institutes of Health (NIH), Simons Autism Foundation, Cancer Council of Victoria, CRC for Mental Health, Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, and Geelong Medical Research Foundation.